Fincanna Capital Corp
Change company Symbol lookup
Select an option...
FNNZF Fincanna Capital Corp
MIRM Mirum Pharmaceuticals Inc
FCELB Fuelcell Energy Inc
UK Ucommune International Ltd
CRDF Cardiff Oncology Inc
TRNR Interactive Strength Inc
OMGA Omega Therapeutics Inc
ACST Acasti Pharma Inc
PYPD PolyPid Ltd
ACRX AcelRx Pharmaceuticals Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Based in Canada
Company profile

FinCanna Capital Corp. is a Canada-based investment company. The Company is focused on targeted sectors of the cannabis supply chain through direct royalty or equity investments and strategic joint venture partner relationships. The Company has no active business operations.

Price
Delayed
$0.0012
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Heavy Day)

Today's volume of 520 shares is on pace to be much greater than FNNZF's 10-day average volume of 520 shares.

520

Company Profile

FinCanna Capital Corp. is a Canada-based investment company. The Company is focused on targeted sectors of the cannabis supply chain through direct royalty or equity investments and strategic joint venture partner relationships. The Company has no active business operations.

Valuation Ratios

No valuation ratios available.

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

No short interest available.

Share Information

FNNZF is in a share class of common stock
Float
893.9M
Shares Outstanding
895.3M
Institutions Holding Shares
--
--

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

No company officers listed.

Address

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.